Intra-Operative Corticosteroid Injection During Arthroscopic Shoulder

Status Terminated

Clinical Trial Summary

The purpose of this study is to assess the efficacy of intra-operative subacromial corticosteroid injections in patients undergoing arthroscopic shoulder surgery on quality of life scores and activity level when compared to a control group.

Clinical Trial Description

This study is designed to assess whether a subacromial injection of corticosteroids at the time of arthroscopic shoulder surgery influences quality of life scores and activity level when compared to a control group. The hypothesis is that intra-operative subacromial corticosteroid injection after arthroscopic subacromial decompression surgery will provide a more rapid improvement in quality of life scores and activity levels in the post-operative period compared with controls. The study will be a placebo-controlled, double-blind prospective study. All patients necessitating arthroscopic shoulder surgery presenting to Dr. Keith Baumgarten's clinics are eligible for participation. If the patient meets the inclusion criteria, then informed consent will be obtained for participation in this study. Each patient will undergo a standard shoulder exam to assess active range of motion and complete demographics and pre-operative patient determined outcomes surveys (1. Disabilities of the Arm, Shoulder, and Hand (DASH) 2. Simple Assessment Numeric Evaluation (SANE) 3. Western Ontario Rotator Cuff (WORC)) and the Marx shoulder activity level survey (MARX). Patients will then undergo arthroscopic shoulder surgery. After arthroscopic surgery the experimental group will undergo a subacromial corticosteroid injection + marcaine while the control group will undergo a subacromial marcaine injection. Outcomes will be assessed using the same quality of life surveys and an activity level survey at post-operative visits at the time intervals: 2 weeks and 3 months and by U.S. mail at 5 months and 1 year. Active range of motion will be assessed at post-operative visits: 2 weeks, 6 weeks, and 3 months. Subjects that meet criteria to undergo arthroscopic shoulder surgery will be provided informed consent to receiving either a subacromial corticosteroid injection or placebo injection at the end of surgery. Patients will be expected to complete all pre- and post-operative quality of life surveys and activity level surveys. It will take less than 20 minutes to complete all listed surveys at each pre- and post-operative visit. Active range of motion will be assessed at each post-operative visit and subjects will be expected to take part in this physical examination as well. The duration of subject participation is 1 year from the date of initial surgery. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02867904
Study type	Interventional
Source	University of South Dakota
Contact
Status	Terminated
Phase	Phase 4
Start date	March 2016
Completion date	April 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04101266` - Pain Management in Arthtroscopic Shoulder Surgery	N/A
Not yet recruiting	`NCT04152135` - Hemodynamic Changes With Passive Leg Raising Maneuver in Patients Undergoing Arthroscopic Shoulder Surgery
Completed	`NCT01351363` - Prediction Of Post Operative Pain Following Arthroscopic Shoulder Surgery	N/A
Completed	`NCT03691922` - Erector Spinae Block Versus Shoulder Periarticular Anesthetic Infiltration for Arthroscopic Shoulder Surgery	N/A
Not yet recruiting	`NCT03602469` - Postoperative Analgesia of Magnesium Sulfate in Suprascapular Nerve Block Following Shoulder Arthroscopy	N/A
Not yet recruiting	`NCT03738735` - Randomized, Controlled Trial of Hyperosmotlar Saline for Rotator Cuff Repair Irrigation Solution	Phase 4
Recruiting	`NCT05739201` - ISB, SSNB, and PENG Block for Arthroscopic Shoulder Surgery	N/A
Terminated	`NCT04633837` - Examining the Effectiveness of a Connective Tissue Matrix Implant in Reducing Post-operative Pain and Narcotic After Outpatient Arthroscopic Shoulder Surgery	N/A
Completed	`NCT04669639` - A Comparison of ESP Block to SSN Block for Analgesia in Shoulder Surgery	N/A
Active, not recruiting	`NCT04675671` - Analgesic and Anxiety Efficacy of Preemptive Pregabalin
Completed	`NCT03277326` - Interscalene vs Anterior and Posterior Suprascapular Nerve Block for Shoulder Arthroscopic Surgeries	N/A
Recruiting	`NCT00731146` - Effects of Technique on the Local Anesthetic Dose Required for Interscalene Brachial Plexus Block	N/A
Completed	`NCT03212443` - Combined Suprascapular and Axillary Nerve Blocks for Arthroscopic Shoulder Surgery	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Intra-Operative Corticosteroid Injection During Arthroscopic Shoulder Surgery

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms